Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections

Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections

US Patent 12298305 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Silicified cell replicas, methods of making, and methods of using2025
Modulators of GTPases and their use2025
Living mammalian cells modified with functional modular nanoparticles2025
Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers 2024
Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers 2024
Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers 2024
Silicified cell replicas, methods of making, and methods of using2024
Modulators of GTPases and their use2023
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021